![]() |
Figure 2: Results of immunohistochemical studies of skin of a healthy volunteer and a patient with vitiligo before treatment (а) CD1a+ cells in skin of a healthy person ×400, (b) CD1a+ cells in lesional skin of a patient with vitiligo×200, (с) CD1a+ cells in marginal skin of a patient with vitiligo×200, (d) CD1a+ cells in perilesional normally pigmented skin of a patient with vitiligo×200. (е) CD83+ dendritic cells in skin of a healthy person х100, (f) CD83+ dendritic cells in lesional skin of a patient with vitiligo×400, (g) CD83+ dendritic cells in marginal skin of a patient with vitiligo×400, (h) CD83+ dendritic cells in perilesional normally pigmented skin of a patient with vitiligo×400. (i) CD4+ lymphocytes in skin of a healthy person ×100, (j) CD4+ lymphocytes in lesional skin of a patient with vitiligo×400, (k) CD4+ lymphocytes of marginal skin of a patient with vitiligo×400, (l) CD4+ lymphocytes in perilesional normally pigmented skin of a patient with vitiligo×400. (m) CD8+ lymphocytes in skin of a healthy person ×100, (n) CD8+ lymphocytes in lesional skin of a patient with vitiligo×200, (o) CD8+ lymphocytes in marginal skin of a patient with vitiligo×400, (p) CD8+ lymphocytes in perilesional normally pigmented skin of a patient with vitiligo×400. |